论文信息 - Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts). - 字舞流文

Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts).

J. Mosser | F. Penault-Llorca | J. Soria | J. Mazières | H. Blons | G. Zalcman | J. Merlio | P. Jonveaux | M. Denis | F. Barlesi | L. Ouafik | I. Rouquette | F. Nowak | P. Bringuier | M. Beau-Faller | F. Morin | D. Debieuvre | P. Missy | J. Cadranel | C. Maréchal | Intergroupe Francophone de Cancerologie Thoracique